6. Parkinson disease
2,123 clinical trials,   2,046 drugs   (DrugBank: 324 drugs),   183 drug target genes,   198 drug target pathways

Searched query = "Parkinson disease"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
2 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00129675
(ClinicalTrials.gov)
February 200311/8/2005Study of Individuals With Parkinson's Symptoms But in Whom There is Diagnostic UncertaintyDevelopment of a Imaging Marker for Parkinson's Disease Through Use of Dynamic SPECT Imaging With [123I] Beta-CIT in Individuals With Parkinson's SymptomsParkinsonian SyndromeDrug: [123I]ß CITInstitute for Neurodegenerative DisordersMolecular NeuroImagingCompleted21 YearsN/ABoth169Phase 2United States
2NCT00117819
(ClinicalTrials.gov)
March 200130/6/2005A Study of Brain Imaging With Nuclear Medicine Technology in Individuals With and at Risk for Parkinson's DiseaseDynamic SPECT Imaging With [123I] B-CIT in Individuals With Parkinsonian Syndrome (PS) and in Individuals at Risk for Parkinsonian SyndromeParkinsonian SyndromeDrug: [123I]ß CIT and SPECT imagingInstitute for Neurodegenerative DisordersIndiana University;Albany Medical CollegeCompleted22 YearsN/ABoth232Phase 2United States